The ability to achieve precision healthcare — care that is personalized, patient-centered, and accessible — will depend on new ways of generating evidence that informs treatment decisions in the clinic, regulatory decisions by the U.S. Food and Drug Administration and its international counterparts, and coverage and payment decisions by Medicare and other payers.
Read More